JIC
TCRT icon

Johnson Investment Counsel’s Alaunos Therapeutics TCRT Stock Holding History

Johnson Investment Counsel’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-72
Closed -$130K – 569
2015
Q2 		$130K Buy
72
+5
+7% +$7.76K ﹤0.01% 529
2015
Q1 		$107K Sell
67
-200
-75% -$296K ﹤0.01% 537
2014
Q4 		$202K Hold
267
– – 0.01% 536
2014
Q3 		$105K Hold
267
– – ﹤0.01% 549
2014
Q2 		$161K Hold
267
– – 0.01% 491
2014
Q1 		$183K Hold
267
– – 0.01% 491
2013
Q4 		$173K Hold
267
– – 0.01% 495
2013
Q3 		$157K Hold
267
– – 0.01% 485
2013
Q2 		$84K Buy
+267
New +$74.1K ﹤0.01% 501

Other funds holding TCRT

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Johnson Investment Counsel's TCRT Position: Q3 2015 in Review

Johnson Investment Counsel sold out of Alaunos Therapeutics (TCRT) in Q3 2015, closing a stake of 72 shares — an estimated $130K sold.

Johnson Investment Counsel first reported a position in TCRT in Q2 2013 and held it in 9 quarters. The position peaked at $202K in Q4 2014. 138 funds tracked by Wall St. Rank hold TCRT as of Q3 2015.

  • Johnson Investment Counsel reported no remaining Alaunos Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Johnson Investment Counsel sold 72 Alaunos Therapeutics shares in Q3 2015, an estimated $130K.
  • Johnson Investment Counsel first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 9 quarters.
  • Johnson Investment Counsel's Alaunos Therapeutics position peaked at $202K in Q4 2014.
  • 138 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2015.

Based on Johnson Investment Counsel's 13F filing for Q3 2015, filed 16 Nov 2015.